TMCnet News
Research and Markets: Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014Research and Markets (http://www.researchandmarkets.com/research/rf7rzz/amyotrophic) has announced the addition of the "Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Amyotrophic Lateral Sclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Amyotrophic Lateral Sclerosis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergo periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensre that the most recent developments are captured on a real time basis. Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/rf7rzz/amyotrophic |
